Updated Oct 28, 2026 · 12:56 UTC

ALNYAlnylam Pharmaceuticals, Inc.

Health Care · United States · XNAS · pharmaceutical preparations
$225.32−0.38%last session · market early-hours
Market cap
$30.15b
real-world
Tokenized
$42
<0.001% of the asset
Avg token price
$225.88
Spot volume, 24h
—
Derivatives, 24h
—
Perp open interest
—
In DeFi
—
ALNY · Price

EarningsNasdaq’s earnings calendar

Next earnings
Oct 29
before the open · Sep 2026 quarter · EPS forecast $1.46 (9 analysts)
Last earnings, Jul 30
$1.21 EPS
−16.0% vs $1.44 forecast · Jun 2026 quarter

Real marketAlnylam Pharmaceuticals, Inc.

Last close
$226.79
Oct 27
Traded on Oct 27
$362.2m
Price now
$225.32
market early-hours

Where it trades24h volume by venue, as the exchanges report it · open interest and funding on the perpetuals

Spot · — · 0 venues
None yet
Derivatives · — · 0 venues
None yet

In DeFiPools and lending markets that hold these tokens

None found

Onchain versions1 token from 1 issuer

wALNYxBacked Assets——

Business Quarter to Jun 2026 · SEC EDGAR

Revenue
$1.29b
Net income
$164.5m
13% margin
Cash
$1.71b
10-Q filed Jul 30, 2026 ↗

Quarterly

Jun '25Jun '26
RevenueNet income